It was shown that heightened IFN-γ levels are generally tumor-suppressive [8, 19], and that deficiency of IFN-γ or its receptor-promoted colorectal carcinogenesis [20], thus prompting the conclusion of a key role for IFN-γ in patient survival [3, 21]. This evidence concerns the gene IFNG and neoplasm.